Kymera Therapeutics posted 0% EPS growth in its most recent report, while sales growth came in at 115%. The company earns the No. 109 rank among its peers in the Medical-Biomed/Bi ...

On Friday, iTeos TherapeuticsITOS got a positive adjustment to its Relative Strength (RS) Rating, from 70 to 76. Please watch the video at Investors.com - How To Trade Options: Choosing The Right ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Does Catalyst Pharmaceutical (CPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Everyone has their own methods for finding great value opportunities, but our model ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Detailed price information for Catalyst Pharm Inc (CPRX-Q) from The Globe and Mail including charting and trades.

The stock's fall snapped a two-day winning streak.

This was the stock's second consecutive day of gains.